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AbstrAct
Introduction The Cochrane Collaboration aims 
to produce relevant and top priority evidence that 
responds to existing evidence gaps. Hence, research 
priority setting (RPS) is important to identify which 
potential research gaps are deemed most important. 
Moreover, RPS supports future health research to 
conform both health and health evidence needs. 
However, studies that are prioritising systematic review 
topics in public health are surprisingly rare. Therefore, 
to inform the research agenda of Cochrane Public 
Health Europe (CPHE), we introduce the protocol of a 
priority setting study on systematic review topics in 
several European countries, which is conceptualised 
as pilot.
Methods and analysis We will conduct a two-round 
modified Delphi study in Switzerland, incorporating an 
anonymous web-based questionnaire, to assess which 
topics should be prioritised for systematic reviews in 
public health. In the first Delphi round public health 
stakeholders will suggest relevant assessment criteria 
and potential priority topics. In the second Delphi 
round the participants indicate their (dis)agreement to 
the aggregated results of the first round and rate the 
potential review topics with the predetermined criteria 
on a four-point Likert scale. As we invite a wide variety 
of stakeholders we will compare the results between 
the different stakeholder groups.
Ethics and dissemination We have received ethical 
approval from the ethical board of the University of 
Bremen, Germany (principal investigation is conducted 
at the University of Bremen) and a certificate of non-
objection from the Canton of Zurich, Switzerland 
(fieldwork will be conducted in Switzerland). The 
results of this study will be further disseminated 
through peer reviewed publication and will support 
systematic review author groups (i.a. CPHE) to improve 
the relevance of the groups´ future review work. 
Finally, the proposed priority setting study can be used 
as a framework by other systematic review groups 
when conducting a priority setting study in a different 
context.
IntroductIon
Research Priority Setting
Organisations conducting or funding public 
health research have to select research prior-
ities while often facing competing demands 
and scare resources.1 Without research 
priority setting (RPS) there is a risk that 
research topics will be chosen ad hoc or 
strengths and limitations of this study
 ► We expect that this structured research priority 
setting study is developed in such a way that it 
can serve as a framework for, and can easily be 
replicated by, other systematic review author groups.
 ► Our recruitment strategy, in which organisations 
themselves are invited to nominate respondents 
from within their own organisation for participating 
in the study, increases the likelihood that the 
invited individuals will participate and allows for 
a participation of individuals who are considered 
to have the most expertise for contributing to the 
research.
 ► We include a wide variety of stakeholders that are 
affiliated to the field of public health in order to get 
a clear overview of the evidence needs that are 
present in public health.
 ► Although our modified Delphi technique cannot 
be considered a full Delphi study due to the lack 
of an additional feedback round, it does include 
a combination of metrics- and consensus-based 
priority setting techniques and it ensures the 
involvement of stakeholders who otherwise would 
likely be overshadowed in a full consensus-building 
procedure.
 ► We use purposive sampling to include participants 
who have the expertise necessary to optimally 
respond to the questions raised. However, this might 
also lead to the inclusion of respondents who are 
interested in participating in research and who may 
differ from those who do not want to participate.
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Figure 1 Stages of the proposed Research Priority Setting study.
are determined by funders based on subjective goals.2–4 
Hence, RPS exercises are conducted to identify and rank 
the most important and beneficial research options while 
taking current health evidence into account.5–7
Although the need to produce relevant and top priority 
evidence for health is widely supported a general frame-
work for conducting a priority setting exercise in health 
research does not exist7–10 and might not be realisable 
due to contextual factors of different RPS exercises.8 
Furthermore, RPS exercises specifically focused on public 
health topics are rare.
research Priority setting within cochrane
The proposed study is conducted on behalf of Cochrane 
Public Health Europe (CPHE). CPHE is a subdivision 
of Cochrane Public Health, which aims to produce and 
publish Cochrane reviews regarding the effects of public 
health interventions. In general, Cochrane entities want 
to produce relevant and top priority evidence – which 
is also highlighted by one of their key principles for the 
production of systematic reviews: ‘Striving for relevance’.11 12 
In order to select the most relevant and important review 
topics some type of RPS is necessary.
So far, Cochrane Review Groups use a wide variety of 
frameworks, approaches, and methods for assessing which 
review topics should be prioritised and a more rigorous 
and transparent process for priority setting is needed.12–14 
One study showed that 23 out of 52 questioned Cochrane 
Review Groups did not have a process for prioritising 
review topics at all and only 13 out of 52 used a trans-
parent and structured process for prioritising their review 
work.13 Of these 13 Review Groups the following prioriti-
sation processes could be identified13:
1. Selecting priority topics according to health status 
data and policy reports.
2. Identifying potential priority topics from the gaps in 
existing evidence.
3. Collecting priority topics from the recommendations 
of e.g. clinical guidelines or other systematic reviews.
4. Gathering priority suggestions from stakeholders 
(eg, including review groups, clinicians, consumers, 
policy-makers).
Although the focus of these process are all important 
features for prioritising research topics in health, they are 
limiting the range of the assessment when investigated 
separately. Therefore, these processes should be included 
as separate stages or as assessment criteria in an overall 
structured priority setting exercise. Multiple stakeholders 
should be invited to participate to ensure that the process 
will be more transparent and not solely based on the 
expertise and research interests of the editorial team.
In order to develop a prioritisation process that is 
informed by existing evidence gaps, recommendations 
from other sources, health impacts, and the input from 
stakeholders, the processes described above need to be 
combined in one structured prioritisation process.
AIMs
The first aim of the proposed priority setting study is to 
implement a structured RPS study in Switzerland to inves-
tigate which systematic review topics within the field of 
public health are rated highest by public health stake-
holders and whether preferences vary significantly by 
stakeholder group. Second, we investigate which assess-
ment criteria are perceived most important by the public 
health stakeholders when prioritising potential review 
topics.
rational
We want to inform systematic review author groups, both 
within and outside of Cochrane Public Health Europe 
(CPHE), to improve the relevance of future review work 
with regards to the needs of public health stakeholders.
Finally, this is the first study in a series of future studies 
in other European countries. Hence, we intend to design 
the study in a way that allows for easy replication by other 
systemic review author groups and for application in 
different countries. This is one of the reasons to choose 
Switzerland: As the country is trilingual we can emulate 
the challenges that adaptation and translation of a survey 
for several language and settings pose. Another reason to 
first conduct this study in Switzerland is because there is a 
good mixture of national and international health organ-
isations present, which increases the likelihood to gather 
suggestions from a wide variety of stakeholders.
Methods and analysis
Study status
We employ a multi-stage process in our study (see 
figure 1): We started mid-2015 with a comprehensive liter-
ature review that preceded the scoping stages of the study. 
In the first scoping stage we established how public health 
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box 1 relevant stakeholder groups - based on27–32
 ► Public Health research and education 
 ► Policy makers at different levels
 ► National & local health organisations (non-governmental & non-
profit organisations – NGOs/NPOs)
 ► International health organisations (NGOs & NPOs): Excluded are 
multilateral/bilateral agencies
 ► Representatives of health professionals and healthcare institutions
 ► Representatives of the public
 ► Health insurers
is defined for the remainder of the study, which stake-
holder groups are relevant for inclusion in the study, and 
which assessment criteria will be used as preselection for 
prioritising the review topics (Pre-Stage I). In the second 
scoping stage we continued with a horizon screening 
of recommendations and statements in existing litera-
ture with regards to potential systematic reviews topics 
(Pre-Stage II).
Pre-Stage I started December 2015 and has been 
completed in October 2016, whereas Pre-Stage II is 
on-going and is planned to be completed in July 2017. 
With regards to the comprehensive literature review 
and the scoping stages we communicated intensively 
with members of Cochrane Public Health Europe. We 
also established an advisory board at the beginning of 
Pre-Stage I and the members have provided valuable 
input for the first two scoping stages and will be involved 
for the remainder of the proposed study. We identified 
120 organisations and institutions, which are affiliated to 
the field of public health in Switzerland, for being invited 
to participate in the Delphi rounds.
We will use a two-round modified Delphi technique to 
prioritise systematic review topics within public health 
(Stage III & IV). The questionnaire for the first Delphi 
round is planned to be sent out in August 2017 and the 
second Delphi round questionnaire is aimed for October 
2017.
Study design
Several studies used the Delphi technique for priori-
tising research options.15–21 The Delphi technique is 
often applied when consensus is sought from a diverse 
group of experts on a range of topics or ideas.21–23 
Participants are encouraged to provide controlled feed-
back in multiple rounds, which allows them to reassess 
and/or change their opinion according to the results 
of previous rounds.23 Additionally, the Delphi process 
allows for an easy incorporation of both metrics- and 
consensus-based techniques and it does not require 
face-to-face meetings. Therefore, the Delphi technique 
does not only reduces resource expenses but it also 
reduces potential disadvantages of a face-to-face expert 
panel such as social pressure and dominance of certain 
individuals or groups.7 21 23 24
Our modified Delphi cannot be considered as a full 
Delphi study because the rating exercise that will be 
conducted in the second questionnaire will not be avail-
able for a discussion in another follow-up round. We 
modified the Delphi process as such to reduce the work-
load for the respondents and to be able to include more 
stakeholders. Therefore, the results of the proposed 
Delphi procedure should be interpreted as an indication 
of preferences rather than a true consensus. On the other 
hand this modified process increases the involvement of 
stakeholders who otherwise might be overshadowed in 
the discussion of a full Delphi study, or who would not 
be invited at all as one of the top expert for a Delphi 
study.23 25
In the first Delphi round we will ask relevant stake-
holders in an online questionnaire to propose and select 
systematic review topics that they consider to be poten-
tial priorities and to select which assessment criteria they 
deem essential for assessing the importance of potential 
review topics (Stage III). Finally, in the second Delphi 
round a second questionnaire will be distributed to the 
same stakeholders in which they are invited to provide 
feedback to the results of the first questionnaire and to 
rate the proposed topics from the first Delphi round 
according to the selected assessment criteria (Stage IV).
Advisory board
It is recommended that a RPS study is overseen and 
guided by an advisory or steering group.7 8 26 Hence, our 
proposed study will be conducted with the support of an 
advisory board – consisting of both subject matter experts 
and methodological experts from three different coun-
tries. We purposefully chose advisory board members 
who have a lot of experience with combining practice 
and research in their work. More information about the 
advisory board members can be found in the acknowledg-
ments. The advisory board members oversee the design 
and the analysis of the study especially with regards to the 
scope of the study, the selection of relevant participants 
for the Delphi process, the questionnaire design, and the 
interpretation of the Delphi results.
Participant selection and recruitment
Part of the core principles of Cochrane Public Health is to 
produce accessible evidence which can be disseminated 
to potential users of public health evidence. Therefore, 
it is important that the needs of those potential users 
are also taken into account with regards to the choice of 
future review topics.
In our study we will explore the needs (or preferences) 
of potential users of public health research evidence so 
that their perceived needs can be incorporated in the 
direction of future reviews. We decided to approach a 
wide variety of stakeholder groups (box 1).
As commonly adopted in Delphi studies we will use 
purposive sampling for both questionnaires that will 
be conducted in our study. In purposeful sampling the 
respondents do not have to represent a broader popu-
lation. It only has to be ensured that the respondents 
have the expertise to participate and to provide insightful 
responses regarding the study subject.33 Nevertheless, it 
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Table 1 Main domains of public health research
Domains Key Words
Prevention Surveillance / modelling / control of 
diseases & other health conditions
Health 
promotion
Health information / health competences / 
healthy behaviour & environments
Health services Medical care / health systems & services
Table 2 Preselected assessment criteria
Equity The review topic will be likely to reduce 
inequity in the accessibility of health 
interventions.
Effectiveness The review topic will be likely to 
generate/improve effective health 
interventions.
Disease burden 
reduction
The review topic will have a theoretical 
potential to reduce large portions of the 
existing disease burden.
Feasibility The review topic will be deliverable 
within its context.
Novelty of the 
concept
The review topic represents a new or 
emerging area.
Lack of (good 
quality) evidence
Synthesised evidence for the review 
topic is either not existing, lacking in 
quality, not up to date, or only available 
in a different context.
is important to include a wide variety of stakeholders in 
order to not under- or over-represent certain stakeholder 
groups.
Our recruitment method is based on a successful priority 
setting study conducted by the German Network for 
Healthcare Research (Deutsches Netzwerk Versorgungs-
forschung) in which organisations themselves are invited 
to nominate respondents from within their own organisa-
tion for participating in the study.20 This method increases 
the likelihood that the invited individuals will participate 
and it allows for a selection of individuals who are consid-
ered to have the most expertise for contributing to the 
research.
We will contact directors or heads of departments of 
all stakeholder organisations that are identified for the 
proposed study in Pre-Stage I and we will ask them to nomi-
nate individuals from their organisation that are most 
suitable for participating in the study. If they nominate 
individuals then we can see this as an informed consent 
from the directors or heads of departments. At the begin-
ning of both questionnaires the respondents themselves 
will be further informed about that their participation is 
voluntarily and anonymous; the questionnaires will only 
start after their informed consent.
Approximately 120 organisations and institutions in 
Switzerland that are associated to public health will be 
invited to nominate participants for the proposed priority 
setting study. Each invited organisation and institution 
will be asked to nominate minimal five individuals to 
participate in the two Delphi rounds. The same recruit-
ment method in the priority setting study of the German 
Network for Healthcare Research showed that about 75% 
of the organisations nominated respondents.20 Most of 
these nominees participated in the study (85%). Based on 
these results we could expect to have a maximum of 380 
respondents. However it is not unlikely that participating 
organisations will nominate less than five individuals, 
hence we expect the final number of respondents to be 
lower than 380.
A disadvantage of the Delphi technique is that the panel 
attrition rates are high and increase when the number 
of rounds increases.34 35 Based on a study that compared 
online Delphi studies,34 we expect an attrition rate of 
10.5% from round one to round two. The risk of drop-
outs is reduced due to the chosen recruitment strategy 
and due to the included function that allows respon-
dents to save their progress in the questionnaire and to 
continue later.
scoping stages
Pre-Stage I – Scoping the study
Before the actual prioritisation will be undertaken (stage 
III & IV) we needed to define the scope of the proposed 
study.8 36 37 With input from the advisory board we estab-
lished:
 ► The domains of public health research that needed to 
be included in this RPS study.
 ► The stakeholder groups that are relevant for inclusion 
in the study.
 ► The assessment criteria that needed to be preselected 
for the Delphi rounds.
Public health domains
We defined three domains of public health research for 
our proposed study (table 1). These domains are based 
on the classification that is made within the European 
SPHERE project.38 The SPHERE project (supported by 
the European Commission's Sixth Framework Research 
Programme) serves as an excellent base for this study 
as it thoroughly reviewed and described public health 
research at the European level.
Stakeholder groups
Information regarding the identified stakeholder groups 
for the proposed priority setting exercise is described in 
the participant selection & recruitment section and an 
overview can be found in box 1.
Assessment criteria
Many RPS studies establish a preliminary list of assess-
ment criteria for assessing the different research 
options.5 7 39 40 Based on recommended assessment 
criteria for RPS studies in health5 41–44 we included six 
assessment criteria as a starting point for this study 
(table 2).
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Pre-Stage II – Horizon screening
Data collection
In Pre-Stage II we are gathering statements regarding 
potential review topics in public health from existing 
literature. The identified review topics will serve as exam-
ples in the first Delphi round, which creates a starting 
point for the respondents for their own listing of poten-
tial review topics.
As horizon screening can become an onerous task we 
based our approach on another RPS study in the field of 
public health.45 We modified their approach as the gath-
ered review topics will only serve as the building blocks 
for the remainder of the study and therefore we do not 
need to gather an extensive list of review topics. We 
are screening explicit electronic databases and sources 
that present high quality systematic reviews (Cochrane 
Library, Health  Evidence. org, Systematic Reviews 
Journal, Evidence for Policy and Practice Information 
and Coordinating) that fit into our set scope (Pre-Stage 
I).
Data analysis
During the horizon screening we analyse the recommen-
dations in the identified reviews for statements regarding 
gaps in research evidence in public health. These gaps in 
the research evidence will be categorised into the main 
public health domains that have been established in 
Pre-Stage I.5 18 42 46
delphi procedure
Stage III – First Delphi round – Gathering of review topics and 
assessment criteria
Data collection
In the first Delphi round an online questionnaire 
(see online supplementary appendix 1) will be distrib-
uted to the stakeholders. They will be invited to propose 
and select systematic review topics for each public health 
domain separately. We compare topics within each 
domain separately because a cross domain comparison of 
topics will be less informative and can lead to interpre-
tation problems. Furthermore, the domains will serve as 
guidance for the respondents allowing them to consider 
all the different directions within public health. The 
respondents need to select review topics which they think 
should be considered as potential priority topics. Simul-
taneously they can indicate if another domain should be 
added or if the definition of the existing domains should 
be adjusted.
From the selected and proposed topics the respondents 
will need to make top three lists. We include this quick 
prioritisation of three topics per domain to investigate 
which review topics are proposed ad hoc as top priorities 
without the consideration of assessment criteria. There-
after, we ask them to select or propose criteria which 
they believe are of particular importance for assessing 
which review topics should be prioritised. We will use the 
selected assessment criteria in the second Delphi round 
for an in-depth prioritising and compare this to the results 
of the quick prioritisation.
In the final part of the first Delphi round the respon-
dents will have to rate their experience with systematic 
reviews on a four-point Likert scale.
Data analysis
The questionnaire will remain online for up to 4 weeks 
and reminders will be sent out via electronic mail approx-
imately every 7 days after the initial invitation. The 
questionnaire will be administered online using Lime 
Survey software. We will use IBM SPSS Statistics (Version 
23) software for further data management and analysis of 
the anonymised database to carry out descriptive statistics 
(frequencies, range of scores).
The results of the first Delphi round will give an exten-
sive list of review topics that are selected or proposed by 
public health stakeholders in Switzerland. The top three 
lists from the quick prioritisation will be pooled into a 
preliminary priority list per domain. Furthermore, we will 
conduct a domain comparison to see if certain domains 
are over- or under-represented in the final priority lists 
and a stakeholder group comparison to see if the different 
stakeholder groups select and prioritise different review 
topics. Finally, we will also count the selected and 
proposed assessment criteria to see which criteria are 
deemed most suitable for assessing review topics. These 
assessment criteria will be used in the second Delphi 
round for the in-depth prioritisation rating.
The proposed topics will be synthesised to reduce the 
overlap between the proposed topics and clustered into 
the established public health domains.5 18 42 46 Thereafter, 
the proposed topics will be reshaped into properly defined 
review topics using the PI(C)O format. In evidence-based 
medicine and evidence-based public health the PICO 
format is used to create review questions that are focused 
on the effect of an intervention or issue. The different 
elements of PICO stand for:
 ► P = Patient, Population, or Problem.
 ► I = Intervention, Item of Interest, exposure, or Issue
 ► C = Comparison (if any)
 ► O = Outcome
The synthesising and redefining of topics will reduce 
the length of the list of options for the second Delphi 
round, improve the definition and therefore the applica-
bility of the listed topics, give insight in how many times 
different topics are proposed and by whom, and provide 
a good overview of which public health areas or domains 
are suggested most often.5 42
Stage IV – Second Delphi round – Rating of review topics with 
assessment criteria
Data collection
In the second Delphi round we will distribute another 
questionnaire to the stakeholders (see online supplemen-
tary appendix 2) showing them the aggregated results of 
the first Delphi round. First the respondents are asked to 
indicate their (dis)agreement with the aggregated results 
– regarding both the quick prioritisation exercise and the 
selected assessment criteria. There will also be an open 
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Table 3 Example of criterion weight calculation
Criterion 1 Criterion 2 Criterion 3 Total
Respondent 1 50 30 20 100
Respondent 2 20 50 30 100
Respondent 3 100 0 0 100
Respondent 4 0 50 50 100
Total points (sum of points given by respondents) 170 130 100 400
Weight ((total points given to criterion / total number 
of respondents) * 100)
(170/400) *100 =
42.5
(130/400) *100 =
32.5
(100/400) *100 =
25
section where respondents are asked to comment on 
their (dis)agreement.
Thereafter, we ask them to rate each review topic indi-
vidually per assessment criteria on a four-point Likert 
scale of importance. Finally, the respondents will be 
asked to weigh the importance of the selected assessment 
criteria. This scoring exercise will give a total score for all 
the assessed review topics: One score with and one score 
without including the attached criteria weights. The ques-
tionnaires will be provided in German, French, Italian, 
and English.
Data analysis
Similar as in Delphi round one the questionnaire of the 
second Delphi round will remain online for up to 4 weeks. 
We will send reminders via electronic mail approxi-
mately every 7 days. Also the second questionnaire will 
be administered online using Lime Survey software while 
questionnaire responses will be entered into IBM SPSS 
Statistics (Version 23). We will analyse the agreement 
statements and the rating exercise, both conducted on a 
four-point Likert scale, using multivariate statistics.
Moreover, the respondents need to weight the criteria: 
They will have to allocate a fictional 100 points to the 
selected assessment criteria based on their perception 
of the criterion´s importance for prioritising review 
topics. The allocation per assessment criterion of all the 
respondents will be added together and then divided by 
the number of respondents, which gives a total weighted 
score for all the separate assessment criteria. This total 
score shows the relative importance of every assessment 
criterion. table 3 shows an example on how the points 
allocated by the respondents to the criteria are trans-
formed into a final criterion weight.
We will calculate a final score for every assessed review 
topic: One total score with and one total score without 
weighting. The review topics that received the highest 
score will be listed (one list for scoring with and one 
list for scoring without weighting) as top priority topics. 
Additionally, we will compare these top priorities with the 
priorities that were derived by the quick prioritisation 
exercise in the first Delphi round.
Finally, we can conduct an inter- and intra-stakeholder 
group comparison. The comparison between stake-
holder groups allows us to analyse (univariate analysis) 
if there are significant differences in the preferences of 
the stakeholder groups. For the intra-stakeholder group 
comparison we want to observe if there is consensus within 
each stakeholder group itself. Consensus within groups 
(when using a four-point Likert scale) will be defined by 
taking the IQR and divide it by two.18 47
EthIcs And dIssEMInAtIon
The data from the online questionnaire are automati-
cally stored in a database on a local university server. The 
server is only accessible with a username and a password 
that are only known to the main investigators. Also the 
online questionnaire software provider (Lime Survey) 
does not have access to the database. The username and 
password will not be shared with other parties.
Participation in this study is voluntary. We will provide 
detailed information during the recruitment phase with 
regards to the study in general and to the tasks of the 
respondents so they can make an informed decision. 
Responses will not be traced back to the respondent. No 
personally identifiable information is captured; unless the 
respondent voluntarily offers personal or contact infor-
mation in any of the comment fields (however this is not 
requested in any way). We will not ask the respondents to 
indicate which organisations or institutes they represent. 
Therefore, we can also not report this information in any 
publication.
dissemination
This results of this study will be disseminated through a 
PhD Thesis, the CPHE website, peer reviewed publica-
tions, academic conferences, and possibly through formal 
presentations to the stakeholders. Finally, the study is 
designed in such a way that other systematic review teams 
can use it to recreate and conduct their own priority 
setting studies in different contexts (using free software).
dIscussIon
This priority setting study will involve a wide variety of 
stakeholders in the prioritisation process of public health 
review topics, as is recommended and applied by other 
larger scale projects such as the James Lind Alliance and 
the Healthy People initiative.26 44 48 Therefore the results 
will not only represent the expertise and preferences of 
editorial teams and review groups themselves, but also the 
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evidence needs in practice. Moreover, due to the online 
application and the promising recruitment strategy, we 
believe that this study will produce a large pool of sugges-
tions and priority topics, providing new insight for review 
groups working with public health related topics.
This study design has several limitations. Because we 
modified the Delphi process to reduce the workload for 
the respondents and to be able to produce quicker results 
once this pilot study is applied in a different context, the 
results should be interpreted as an indication of pref-
erences rather than a true consensus.49 Although our 
online modified Delphi study allows for the inclusion of 
a larger panel group than most other Delphi studies, it 
is also reducing the chance for respondents to discuss 
arguments and counterarguments for prioritising certain 
topics. However, by using this process we provide each 
respondent with an equal chance to propose and reas-
sess potential priority topics, which should ensure that 
the final rating is not only informed by the perspectives 
of single (strong) individuals. This reduces the attrition 
of individuals with minority views, therefore leading to a 
more balanced results without an overestimation in the 
final ‘consensus’.
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